advertisement
Ophthalmology and therapy 21
Showing records 1 to 21 | Display all abstracts in Ophthalmology and therapy109490 Evaluation of the Glaucomatous Macular Damage by Chromatic Pupillometry
Quan Y
Ophthalmology and therapy 2023; 12: 2133-2156
109916 Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System
Panfil C
Ophthalmology and therapy 2023; 12: 2641-2655
109282 Efficacy and Safety of Pairing iStent Inject Trabecular Micro-Bypass and iAccess Precision Blade Goniotomy in Patients with Open-Angle Glaucoma
Gallardo MJ
Ophthalmology and therapy 2023; 12: 1973-1987
109555 Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
Quaranta L
Ophthalmology and therapy 2023; 12: 2227-2240
109490 Evaluation of the Glaucomatous Macular Damage by Chromatic Pupillometry
Quan Y; Duan H
Ophthalmology and therapy 2023; 12: 2133-2156
109282 Efficacy and Safety of Pairing iStent Inject Trabecular Micro-Bypass and iAccess Precision Blade Goniotomy in Patients with Open-Angle Glaucoma
Porter M
Ophthalmology and therapy 2023; 12: 1973-1987
109555 Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
Novella A
Ophthalmology and therapy 2023; 12: 2227-2240
109916 Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System
Chauchat L
Ophthalmology and therapy 2023; 12: 2641-2655
109555 Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
Tettamanti M
Ophthalmology and therapy 2023; 12: 2227-2240
109916 Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System
Guerin C
Ophthalmology and therapy 2023; 12: 2641-2655
109490 Evaluation of the Glaucomatous Macular Damage by Chromatic Pupillometry
Zhan Z
Ophthalmology and therapy 2023; 12: 2133-2156
109555 Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
Pasina L
Ophthalmology and therapy 2023; 12: 2227-2240
109490 Evaluation of the Glaucomatous Macular Damage by Chromatic Pupillometry
Shen Y
Ophthalmology and therapy 2023; 12: 2133-2156
109916 Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System
Rebika H
Ophthalmology and therapy 2023; 12: 2641-2655
109555 Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
Weinreb RN
Ophthalmology and therapy 2023; 12: 2227-2240
109916 Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System
Sahyoun M
Ophthalmology and therapy 2023; 12: 2641-2655
109490 Evaluation of the Glaucomatous Macular Damage by Chromatic Pupillometry
Lin R
Ophthalmology and therapy 2023; 12: 2133-2156
109916 Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System
Schrage N
Ophthalmology and therapy 2023; 12: 2641-2655
109490 Evaluation of the Glaucomatous Macular Damage by Chromatic Pupillometry
Liu T
Ophthalmology and therapy 2023; 12: 2133-2156
109555 Adherence and Persistence to Medical Therapy in Glaucoma: An Overview
Nobili A
Ophthalmology and therapy 2023; 12: 2227-2240
109490 Evaluation of the Glaucomatous Macular Damage by Chromatic Pupillometry
Zhang T; Wu J; Huang J; Zhai G; Song X; Zhou Y; Sun X
Ophthalmology and therapy 2023; 12: 2133-2156